CWM
GSK icon

Centricity Wealth Management’s GSK GSK Stock Holding History

Centricity Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$25.3K Buy
658
+4
+0.6% +$153 0.02% 234
2025
Q1 		$25.3K Buy
654
+4
+0.6% +$146 0.02% 228
2024
Q4 		$22K Buy
+650
New +$23.4K 0.02% 243

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Centricity Wealth Management's GSK Position: Q2 2025 in Review

Centricity Wealth Management increased its GSK (GSK) stake by 0.61% in Q2 2025, buying an estimated $153 and bringing the position to 658 shares worth $25.3K. The position accounts for 0.02% of the portfolio, ranked #234.

Centricity Wealth Management first reported a position in GSK in Q4 2024 and has held it in 3 quarters since. The position peaked at $25.3K in Q1 2025. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Centricity Wealth Management held 658 shares of GSK worth $25.3K as of Q2 2025.
  • Centricity Wealth Management bought 4 GSK shares in Q2 2025, an estimated $153.
  • GSK made up 0.02% of Centricity Wealth Management's portfolio in Q2 2025, its #234 holding.
  • Centricity Wealth Management first reported a position in GSK in Q4 2024 and has held it in 3 quarters since.
  • Centricity Wealth Management's GSK position peaked at $25.3K in Q1 2025.
  • 891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.